- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04146766
Effectiveness of eHealth on the Self-management of Health Status and QOL Among CAD Patients
March 1, 2021 updated by: Hui-Hsun Chiang, National Defense Medical Center, Taiwan
Effectiveness of eHealth on the Self-management, Physiological Health and Quality of Life Among Coronary Artery Disease Patients
This article uses the smart medical case management tracking system, combined with various terminal devices to fully record the measured data (pulse, blood pressure) for case home care tracking to prevent the occurrence and deterioration of the disease.
Therefore, with the promotion of the eHealth medical staff and members of the family can instantly grasp the health of the body and cultivate the habits of self-health management and enhance the quality of care.
Therefore, we hope to use the Smart Health Cloud as an interventional measure to improve the care of patients with coronary artery disease, improve self-management ability and quality of life.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The World Health Organization points out that cardiovascular disease is the number one killer of global deaths, killing 17.1 million people worldwide each year, accounting for 31% of the world's total deaths.
Heart disease is the second leading cause of death in China.
Coronary artery disease (CAD) is the majority, and coronary artery disease is the most common cardiovascular disease.
Good self-management can reduce disease risk factors and improve related prognosis.
It is also an important issue in health promotion around the world.
This article uses the smart medical case management tracking system, combined with various terminal devices to fully record the measured data (pulse, blood pressure) for case home care tracking to prevent the occurrence and deterioration of the disease.
Therefore, with the promotion of the eHealth medical staff and members of the family can instantly grasp the health of the body and cultivate the habits of self-health management and enhance the quality of care.
Therefore, we hope to use the Smart Health Cloud as an interventional measure to improve the care of patients with coronary artery disease, improve self-management ability and quality of life.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei city, Taiwan
- TSGH
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- A patient who is 20 years of age or older and has a Coronary computed tomography angiography >50% vascular stenosis, has been PTCA、stent or CABG
- Taiwanese, understand Chinese
Exclusion Criteria:
- Those who can't express their wishes clearly (such as Azheimer's disease, mental dysfunction)
- mental disorder
- infectious diseases
- Patients who participate in other research projects
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: eHealth
Provide home physiology measurement services, including automatic uploading of measured blood pressure values to the cloud, serial back-end education platform to provide numerical anomaly alarms and health care notifications, monthly measurement data reports, combined with mobile APP management system for immediate enquiry .
In addition to the electric visit to the patient's health education guidance, the content includes: 1. Encourage the walking exercise to perform 2. Ask the walking exercise execution progress, please return the daily value of the case to facilitate the record 3. Answer the relevant questions asked during the intervention.
|
The study was randomized (wait-list-control), and it was estimated that 60 subjects were randomly assigned to the immediate treatment group and the wait-list-control group.
The two groups were tested for baseline before intervention in the eHealth.
After the first questionnaire evaluation, the experimental group was involved in the eHealth for three months, and after three months, the experimental group and the waiting intervention control group were post-tested.
To assess the effectiveness of the two groups before and after the eHealth .
Control group that waits for intervention in the fourth month from the beginning of the fourth month to the end of the sixth month
|
|
Experimental: wait list control
wait list control for 3 months and then Provide home physiology measurement services, including automatic uploading of measured blood pressure values to the cloud, serial back-end education platform to provide numerical anomaly alarms and health care notifications, monthly measurement data reports, combined with mobile APP management system for immediate enquiry .
In addition to the electric visit to the patient's health education guidance, the content includes: 1. Encourage the walking exercise to perform 2. Ask the walking exercise execution progress, please return the daily value of the case to facilitate the record 3. Answer the relevant questions asked during the intervention.
|
The study was randomized (wait-list-control), and it was estimated that 60 subjects were randomly assigned to the immediate treatment group and the wait-list-control group.
The two groups were tested for baseline before intervention in the eHealth.
After the first questionnaire evaluation, the experimental group was involved in the eHealth for three months, and after three months, the experimental group and the waiting intervention control group were post-tested.
To assess the effectiveness of the two groups before and after the eHealth .
Control group that waits for intervention in the fourth month from the beginning of the fourth month to the end of the sixth month
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
physiological indicators-HDL-C(T1)
Time Frame: T1-baseline
|
HDL-C, the unit is mg/dL
|
T1-baseline
|
|
physiological indicators-HDL-C(T2)
Time Frame: T2-three months later
|
HDL-C, the unit is mg/dL
|
T2-three months later
|
|
physiological indicators-HDL-C(T3)
Time Frame: T3-six months later
|
HDL-C, the unit is mg/dL
|
T3-six months later
|
|
physiological indicators-LDL-C(T1)
Time Frame: T1-baseline
|
LDL-C, the unit is mg/dL
|
T1-baseline
|
|
physiological indicators-LDL-C(T2)
Time Frame: T2-three months later
|
LDL-C, the unit is mg/dL
|
T2-three months later
|
|
physiological indicators-LDL-C(T3)
Time Frame: T3-six months later
|
LDL-C, the unit is mg/dL
|
T3-six months later
|
|
physiological indicators-Total Cholesterol(T1)
Time Frame: T1-baseline
|
Total Cholesterol, the unit is mg/dL
|
T1-baseline
|
|
physiological indicators-Total Cholesterol(T2)
Time Frame: T2-three months later
|
Total Cholesterol, the unit is mg/dL
|
T2-three months later
|
|
physiological indicators-Total Cholesterol(T3)
Time Frame: T3-six months later
|
Total Cholesterol, the unit is mg/dL
|
T3-six months later
|
|
physiological indicators-Triglyceride(T1)
Time Frame: T1-baseline
|
Triglyceride, the unit is mg/dL
|
T1-baseline
|
|
physiological indicators-Triglyceride(T2)
Time Frame: T2-three months later
|
Triglyceride, the unit is mg/dL
|
T2-three months later
|
|
physiological indicators-Triglyceride(T3)
Time Frame: T3-six months later
|
Triglyceride, the unit is mg/dL
|
T3-six months later
|
|
physiological indicators-GLU(T1)
Time Frame: T1-baseline
|
GLU, the unit is mg/dL
|
T1-baseline
|
|
physiological indicators-GLU(T2)
Time Frame: T2-three months later
|
GLU, the unit is mg/dL
|
T2-three months later
|
|
physiological indicators-GLU(T3)
Time Frame: T3-six months later
|
GLU, the unit is mg/dL
|
T3-six months later
|
|
physiological indicators-HbA1C(T1)
Time Frame: T1-baseline
|
HbA1C, the unit is %
|
T1-baseline
|
|
physiological indicators-HbA1C(T2)
Time Frame: T2-three months later
|
HbA1C, the unit is %
|
T2-three months later
|
|
physiological indicators-HbA1C(T3)
Time Frame: T3-six months later
|
HbA1C, the unit is %
|
T3-six months later
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
self-management-T1
Time Frame: T1-baseline
|
use The partners in Health scale.
total of 12 questions,The scoring method uses the nine-point Likert Scales score.
The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good.
The total score is 96 points.
The higher the score, the better the self-management.
|
T1-baseline
|
|
self-management-T2
Time Frame: T2-three months later
|
use The partners in Health scale.
total of 12 questions,The scoring method uses the nine-point Likert Scales score.
The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good.
The total score is 96 points.
The higher the score, the better the self-management.
|
T2-three months later
|
|
self-management-T3
Time Frame: T3-six months later
|
use The partners in Health scale.
total of 12 questions,The scoring method uses the nine-point Likert Scales score.
The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good.
The total score is 96 points.
The higher the score, the better the self-management.
|
T3-six months later
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life scale-T1
Time Frame: T1-baseline
|
use WHOQOL-BREF Taiwan Version.
total of 28 questions,The scoring method uses the five-point Likert Scales score The questionnaire has a total of 28 questions, with at least one point for each question and a maximum of five points.
The higher the score, the better the quality of life.
|
T1-baseline
|
|
Quality of life scale-T2
Time Frame: T2-three months later
|
use WHOQOL-BREF Taiwan Version.
total of 28 questions,The scoring method uses the five-point Likert Scales score The questionnaire has a total of 28 questions, with at least one point for each question and a maximum of five points.
The higher the score, the better the quality of life.
|
T2-three months later
|
|
Quality of life scale-T3
Time Frame: T3-six months later
|
use WHOQOL-BREF Taiwan Version.
total of 28 questions,The scoring method uses the five-point Likert Scales score The questionnaire has a total of 28 questions, with at least one point for each question and a maximum of five points.
The higher the score, the better the quality of life.
|
T3-six months later
|
|
Modified Health care machine rating scale
Time Frame: T2-three months later
|
There are three questions in the satisfaction survey.
Use category options to measure usage satisfaction
|
T2-three months later
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 18, 2019
Primary Completion (Actual)
July 15, 2020
Study Completion (Actual)
October 5, 2020
Study Registration Dates
First Submitted
October 22, 2019
First Submitted That Met QC Criteria
October 29, 2019
First Posted (Actual)
October 31, 2019
Study Record Updates
Last Update Posted (Actual)
March 3, 2021
Last Update Submitted That Met QC Criteria
March 1, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2-108-05-132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
Mahidol UniversityThe Princess Mantarop Kamalas Foundation, The Nurses' Association of Thailand and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Postoperative Recovery | Coronary Artery Bypass Graft (CABG)Thailand
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
Clinical Trials on eHealth
-
Dartmouth-Hitchcock Medical CenterCompletedObesity | Videoconferencing | mHealth | Technology | Behavior, HealthUnited States
-
UKK InstituteUniversity of Eastern Finland; North Karelia Hospital DistrictUnknown
-
Dr. Danièle PacaudThe Lawson FoundationCompletedDiabetes Mellitus, Type 2Canada
-
University of MiamiNational Cancer Institute (NCI)Not yet recruitingLymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Stem Cell Transplantation | Precursor Cell Lymphoblastic Leukemia-LymphomaUnited States
-
State University of New York at BuffaloUniversity of OregonActive, not recruitingAlcohol AbuseUnited States
-
Aarhus University HospitalRecruitingPersistent Physical SymptomsDenmark
-
Zagazig UniversityCompletedCancer | Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Egypt
-
University of Southern DenmarkOPEN - Odense Patient data Explorative Network, The University of Southern...CompletedDepression, AnxietyDenmark
-
Universitat de GironaCompletedAttention Deficit-hyperactivity DisorderSpain
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedSedentary LifestyleUnited States